Condition: Phelan-McDermid Syndrome · Sponsor: Neuren Pharmaceuticals Limited
This Phase 3, randomized, double-blind, parallel-group (2-arm), placebo-controlled, multicenter study will evaluate the efficacy and safety of NNZ-2591 compared to placebo in pediatric participants with Phelan- McDermid Syndrome.
This description comes directly from the study's public registry record.
Medical Information Lead · 231-203-8050 · medicalinformation@neurenpharma.com
Always discuss trial participation with your own doctor first.
| Neuren PMS-301 Site#122 | Glendale, California, United States | Recruiting |
| Neuren PMS-301 Site #112 | Palo Alto, California, United States | Recruiting |
| Neuren PMS-301 Site#103 | San Diego, California, United States | Recruiting |
| Neuren PMS-301 Site#111 | San Rafael, California, United States | Recruiting |
| Neuren PMS-301 Site#102 | Chicago, Illinois, United States | Recruiting |
| Neuren PMS-301 Site#109 | Chevy Chase, Maryland, United States | Recruiting |
| Neuren PMS-301 Site#106 | Brookline, Massachusetts, United States | Recruiting |
| Neuren PMS-301 Site#104 | Lexington, Massachusetts, United States | Recruiting |
| Neuren PMS-301 Site#101 | New York, New York, United States | Recruiting |
| Neuren PMS-301 Site#108 | Cincinnati, Ohio, United States | Recruiting |
| Neuren PMS-301 Site#115 | Houston, Texas, United States | Recruiting |
| Neuren PMS-301 Site#201 | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07281079